Morning Star: YIDU TECH (02158) has sufficient market liquidity, rated at three stars with a fair value of HK$5.31.

Morningstar published a research report stating that it assigns a three-star rating to YIDU TECH (02158) based on a quantified fair value of HKD 5.31 per share, indicating the company's current stock price has an approximate 12% valuation discount. The company's current stock valuation level is in a relatively balanced range. The company exhibits strong liquidity, and high market trading activity provides support for its valuation. The report notes that YIDU TECH and its subsidiaries rely on their independently developed medical intelligence infrastructure, YiduCore, to offer data analysis services, evidence-based decision support solutions, and operational support services to various participants in the healthcare industry chain. The business is primarily divided into three major segments: AI for Medical, AI for Life Sciences, and AI for Care. Among these, the AI for Medical segment is the largest source of revenue, mainly providing data intelligence platforms and data-driven solutions to hospitals, medical institutions, regulatory agencies, and policymakers. In terms of geography, the company's revenue primarily comes from the mainland China market, followed by Brunei and other overseas markets. Regarding valuation, the company's liquidity level provides some support for quantitative valuation and indicates that the stock may be somewhat undervalued. Ample liquidity helps the company meet short-term debt obligations, enhance financial stability, and reduce financial pressure risks. Higher trading activity may also suggest increased interest from institutional investors. The report also indicates that, aside from fundamental and valuation factors, the company's stock performance over the past year has significantly lagged behind the industry, making its current valuation level appear more attractive, and there is potential for price recovery in the future. Additionally, the report suggests that the company has a high financial health score, indicating a solid asset-liability structure and financial condition, with a certain capability to withstand market pressures and operational fluctuations. Morningstar believes that the liquidity of YIDU TECH provides support for quantitative valuation. Sufficient liquidity can help the company fulfill short-term debts, improve financial stability, and reduce distress risk. For instance, the median trading volume of the company over the past 60 days ranks among the top 20 globally. The active trading of this stock may reflect increased interest from institutional investors and suggests that the current stock price may be undervalued. Furthermore, the model incorporates momentum into its comprehensive analysis. Morningstar believes that the company's performance has lagged behind the market over the past year, and combined with other positive contributing factors from the model, it signals a buying opportunity.